Who we are

Alvotech is a privately owned, fully integrated specialty biopharmaceutical company focused exclusively on the development and manufacturing of high-quality biosimilar products ...

Read more



Our biosimilar assets include several biosimilar monoclonal antibodies and fusion proteins that are developed in our research & development centers located across Europe and are manufactured in our state-of-the-art facility in Reykjavik, Iceland ...

Read more


Alvotech is warming up for CPhI 2019 in Frankfurt

This promises to be a busy and exciting fall for Alvotech. Once more it will be participating in the world's largest pharmaceutical fair, CPhI, which this year is being hosted in Frankfurt, Germany, from 5-7 November 2019.

Read More

Meet management

World Class team

Alvotech brings together a group of world-class pharmaceutical executives with broad backgrounds and extensive experience in the biopharmaceutical industry. The leadership team is led by Alvotech’s CEO Mark Levick and the company’s founder Robert Wessman ... 

Leadership team


Partnering with Alvotech is gaining access to high quality, ready to market biosimilars


We use cookies to ensure our website works properly and to collect statistics about users in order for us to improve the website. Learn more.